CDC: Oropouche Virus Cases Identified in U.S. Travelers Returning From Cuba
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 3, 2024 -- A number of U.S. travelers returning from Cuba have been diagnosed with Oropouche virus, according to research published in the Aug. 27 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that there have been reports of two deaths in patients with Oropouche virus infection and vertical transmission associated with adverse pregnancy outcomes, Andrea Morrison, Ph.D., from the CDC in Atlanta, and colleagues investigated travel-associated Oropouche virus disease cases among U.S. travelers.
The researchers identified 21 Oropouche virus disease cases among U.S. travelers returning from Cuba as of Aug. 16, 2024. Initially, most patients experienced fever, myalgia, and headache, often combined with other symptoms such as arthralgia, diarrhea, nausea or vomiting, and rash. A common characteristic of Oropouche virus disease -- recurrent symptoms after initial illness -- was seen in three patients.
"Because of the risk for possible vertical transmission, providers should inform persons who are pregnant and considering travel to areas with reported Oropouche virus transmission of the possible risks to the fetus," the authors write. "Pregnant travelers should prevent insect bites during travel and consider deferring travel to areas experiencing outbreaks of Oropouche virus disease."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Seroprevalence of HPAI A(H5) Identified in Bovine Veterinary Practitioners
FRIDAY, Feb. 14, 2025 -- Seroprevalence of highly pathogenic avian influenza (HPAI) A(H5) virus infection has been identified among bovine veterinary practitioners, according to...
PTLD Up for Seronegative Recipients of Epstein-Barr Virus-Seropositive Donor Kidneys
WEDNESDAY, Feb. 5, 2025 -- Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased risk for posttransplant...
COVID-19 Linked to More Severe Outcomes Than Flu, RSV in 2022-2023 Season
THURSDAY, Jan. 30, 2025 -- COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.